| --- | --- | |-------------------------|-------| | | | | Molina Healthcare, Inc. | | Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 position, planning, and deployment; our growth plans and prospects; future procurement opportunities; and our financial outlook. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private uncertainties are discussed under Item 1A i ...

Molina Healthcare Inc. (NYSE:MOH) Q3 2019 Earnings Conference Call October 30, 2019 8:00 AM ET Company Participants Julie Trudell - SVP, Investor Relations Joe Zubretsky - President and Chief Executive Officer Tom Tran - Chief Financial Officer Conference Call Participants Scott Fidel - Stephens Inc. Peter Costa - Wells Fargo Securities Josh Raskin - Nephron Research Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America/Merrill Lynch Stephen Tanal - Goldman Sachs Cal Sternick - Cowen and Company St ...

OR Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 ...

Molina Healthcare Inc. (NYSE:MOH) Q2 2019 Earnings Conference Call July 31, 2019 8:00 AM ET Company Participants Julie Trudell - Investor Relations Joe Zubretsky - President and Chief Executive Officer Tom Tran - Chief Financial Officer Conference Call Participants David Windley - Jefferies Peter Costa - Wells Fargo Securities Josh Raskin - Nephron Research Justin Lake - Wolfe Research Sarah James - Piper Jaffray Stephen Tanal - Goldman Sachs Matt Borsch - BMO Capital Markets Ricky Goldwasser - Morgan Stanl ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 (Stat ...

Molina Healthcare, Inc. (NYSE:MOH) Q1 2019 Earnings Conference Call April 29, 2019 8:30 AM ET Company Participants Ryan Kubota - VP, IR Joseph Zubretsky - President and CEO Thomas Tran - CFO Conference Call Participants Shehryar Amir - Wolfe Research Ana Gupte - Leerink Partners LLC Matthew Borsch - BMO Capital Markets Equity Research Joshua Raskin - Nephron Research LLC Sarah James - Piper Jaffray & Co. Kevin Fischbeck - Bank of America Merrill Lynch Dave Styblo - Jefferies LLC Stephen Cano - Goldman Sachs ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 (State or other jurisdiction of (I.R.S. Employer Form 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 or incorporation o ...

| --- | --- | |--------------------------|-------| | | | | | | | | | | 2018 4Q | | | Earnings Call Supplement | | | February 11, 2019 | | | | | | | | Cautionary Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This slide presentation and our accompanying oral remarks contain forward-looking statements regarding, without limitation, our business, operations, turnaround, plans, guidance, projections and longer-term outlook within the meaning of Section 27A of the Sec ...

Molina Healthcare, Inc. (NYSE:MOH) Q4 2018 Earnings Conference Call February 12, 2019 8:30 AM ET Company Participants Ryan Kubota - VP, IR Joseph Zubretsky - CEO Thomas Tran - CFO Conference Call Participants Joshua Raskin - Nephron Research LLC Justin Lake - Wolfe Research LLC Ana Gupte - Leerink Partners LLC David Windley - Jefferies LLC Stephen Tanal - Goldman Sachs & Co. LLC Sarah James - Piper Jaffray & Co. Kevin Fischbeck - Bank of America Merrill Lynch Zachary Sopcak - Morgan Stanley & Co. LLC Gary T ...